Genocea Biosciences Inc. (GNCA) News Nov 20, 2014,
Post# of 250602
Posted On: 11/20/2014 8:52:26 PM
Genocea Biosciences Inc. (GNCA) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on GNCA
U.S. stocks fall; data stoke fears of slowdown 4:31 p.m. Feb. 5, 2014 - Anora Mahmudova
Stocks dip, end off day's lows; Twitter falls after hours: stock market live blog recap 4:27 p.m. Feb. 5, 2014 - blogs.marketwatch.com
3D Systems down on weak outlook, CVS quits cigarettes 4:17 p.m. Feb. 5, 2014 - Sue Chang
Biotech startups find welcome mat withdrawn during IPOs 2:44 p.m. Feb. 5, 2014 - Russ Britt
Other News on GNCA
Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2014 Results - Earnings Call Transcript 12:49 p.m. Nov. 6, 2014 - Seeking Alpha
10-Q: GENOCEA BIOSCIENCES, INC. 11:50 a.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Genocea Up on Positive GEN-003 Data for Genital Herpes - Analyst Blog 1:57 p.m. Oct. 9, 2014 - Zacks.com
10-Q: GENOCEA BIOSCIENCES, INC. 1:06 p.m. Aug. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Genocea Biosciences (GNCA) Chip Clark on Q2 2014 Results - Earnings Call Transcript 10:12 a.m. Aug. 6, 2014 - Seeking Alpha
Genocea starts Phase 2 for herpes drug candidate 8:05 a.m. July 21, 2014 - Seeking Alpha
Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 7.52% - Tale of the Tape 7:44 a.m. July 17, 2014 - Zacks.com
Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape 8:39 a.m. June 23, 2014 - Zacks.com
10-Q: GENOCEA BIOSCIENCES, INC. 1:44 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: GENOCEA BIOSCIENCES, INC. 2:33 p.m. March 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on GNCA
Genocea Named in Top Places to Work List by The Boston Globe 11:52 a.m. Nov. 13, 2014 - BusinessWire - BZX
Genocea to Present at the Stifel Nicolaus 2014 Healthcare Conference 8:04 a.m. Nov. 12, 2014 - BusinessWire - BZX
Genocea Reports Third Quarter 2014 Financial Results 8:01 a.m. Nov. 6, 2014 - BusinessWire - BZX
Genocea Profiles T cell Responses to Identify Antigens Associated with Malaria Episodes 12:01 p.m. Nov. 5, 2014 - BusinessWire - BZX
Genocea to Announce Third Quarter 2014 Financial Results on November 6, 2014 8:04 a.m. Oct. 30, 2014 - BusinessWire - BZX
Genocea Presents Complete Phase 1/2a Data for HSV-2 Immunotherapy at IDWeek 8:03 a.m. Oct. 8, 2014 - BusinessWire - BZX
Genocea Announces $1.2 Million Grant for Malaria Vaccine Discovery 7:01 a.m. Sept. 23, 2014 - BusinessWire - BZX
Genocea to Present at the 21st Annual NewsMakers in the Biotech Industry Conference 8:01 a.m. Sept. 19, 2014 - BusinessWire - BZX
Virology Publishes Genocea HSV-2 Antigen Discovery Paper 8:03 a.m. Sept. 16, 2014 - BusinessWire - BZX
Genocea Commences Phase 2a Trial for GEN-004, Universal Pneumococcal Vaccine Candidate 1:00 p.m. Sept. 11, 2014 - BusinessWire - BZX
Genocea Appoints Kenneth Bate to its Board of Directors 11:30 a.m. Sept. 11, 2014 - BusinessWire - BZX
Genocea Presents Phase 1 Immunology Data for Novel Pneumoccocus Vaccine at ICAAC 3:22 p.m. Sept. 6, 2014 - BusinessWire - BZX
Genocea Reports Second Quarter 2014 Financial Results 10:38 p.m. Aug. 6, 2014 - BusinessWire - BZX
Genocea to Announce Second Quarter 2014 Financial Resultson August 6, 2014 7:02 a.m. July 30, 2014 - BusinessWire - BZX
Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses in Vaccinated Subjects 7:03 a.m. July 22, 2014 - BusinessWire - BZX
Genocea Commences Phase 2 Dose Optimization Trial for GEN-003 HSV-2 Immunotherapy 7:02 a.m. July 21, 2014 - BusinessWire - BZX
Genocea Biosciences, Inc. Elects Not to Pursue Public Offering 10:30 a.m. July 16, 2014 - BusinessWire - BZX
Genocea Biosciences, Inc. Commences Public Offering of Common Stock 6:30 a.m. July 14, 2014 - BusinessWire - BZX
Genocea Announces Positive Top-Line 12-Month Follow-up Data from Phase 1/2a Clinical Trial for HSV-2 Immunotherapy GEN-003 7:02 a.m. July 1, 2014 - BusinessWire - BZX
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer 6:30 a.m. June 24, 2014 - BusinessWire - BZX
MarketWatch News on GNCA
U.S. stocks fall; data stoke fears of slowdown 4:31 p.m. Feb. 5, 2014 - Anora Mahmudova
Stocks dip, end off day's lows; Twitter falls after hours: stock market live blog recap 4:27 p.m. Feb. 5, 2014 - blogs.marketwatch.com
3D Systems down on weak outlook, CVS quits cigarettes 4:17 p.m. Feb. 5, 2014 - Sue Chang
Biotech startups find welcome mat withdrawn during IPOs 2:44 p.m. Feb. 5, 2014 - Russ Britt
Other News on GNCA
Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2014 Results - Earnings Call Transcript 12:49 p.m. Nov. 6, 2014 - Seeking Alpha
10-Q: GENOCEA BIOSCIENCES, INC. 11:50 a.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Genocea Up on Positive GEN-003 Data for Genital Herpes - Analyst Blog 1:57 p.m. Oct. 9, 2014 - Zacks.com
10-Q: GENOCEA BIOSCIENCES, INC. 1:06 p.m. Aug. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Genocea Biosciences (GNCA) Chip Clark on Q2 2014 Results - Earnings Call Transcript 10:12 a.m. Aug. 6, 2014 - Seeking Alpha
Genocea starts Phase 2 for herpes drug candidate 8:05 a.m. July 21, 2014 - Seeking Alpha
Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 7.52% - Tale of the Tape 7:44 a.m. July 17, 2014 - Zacks.com
Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape 8:39 a.m. June 23, 2014 - Zacks.com
10-Q: GENOCEA BIOSCIENCES, INC. 1:44 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: GENOCEA BIOSCIENCES, INC. 2:33 p.m. March 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on GNCA
Genocea Named in Top Places to Work List by The Boston Globe 11:52 a.m. Nov. 13, 2014 - BusinessWire - BZX
Genocea to Present at the Stifel Nicolaus 2014 Healthcare Conference 8:04 a.m. Nov. 12, 2014 - BusinessWire - BZX
Genocea Reports Third Quarter 2014 Financial Results 8:01 a.m. Nov. 6, 2014 - BusinessWire - BZX
Genocea Profiles T cell Responses to Identify Antigens Associated with Malaria Episodes 12:01 p.m. Nov. 5, 2014 - BusinessWire - BZX
Genocea to Announce Third Quarter 2014 Financial Results on November 6, 2014 8:04 a.m. Oct. 30, 2014 - BusinessWire - BZX
Genocea Presents Complete Phase 1/2a Data for HSV-2 Immunotherapy at IDWeek 8:03 a.m. Oct. 8, 2014 - BusinessWire - BZX
Genocea Announces $1.2 Million Grant for Malaria Vaccine Discovery 7:01 a.m. Sept. 23, 2014 - BusinessWire - BZX
Genocea to Present at the 21st Annual NewsMakers in the Biotech Industry Conference 8:01 a.m. Sept. 19, 2014 - BusinessWire - BZX
Virology Publishes Genocea HSV-2 Antigen Discovery Paper 8:03 a.m. Sept. 16, 2014 - BusinessWire - BZX
Genocea Commences Phase 2a Trial for GEN-004, Universal Pneumococcal Vaccine Candidate 1:00 p.m. Sept. 11, 2014 - BusinessWire - BZX
Genocea Appoints Kenneth Bate to its Board of Directors 11:30 a.m. Sept. 11, 2014 - BusinessWire - BZX
Genocea Presents Phase 1 Immunology Data for Novel Pneumoccocus Vaccine at ICAAC 3:22 p.m. Sept. 6, 2014 - BusinessWire - BZX
Genocea Reports Second Quarter 2014 Financial Results 10:38 p.m. Aug. 6, 2014 - BusinessWire - BZX
Genocea to Announce Second Quarter 2014 Financial Resultson August 6, 2014 7:02 a.m. July 30, 2014 - BusinessWire - BZX
Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses in Vaccinated Subjects 7:03 a.m. July 22, 2014 - BusinessWire - BZX
Genocea Commences Phase 2 Dose Optimization Trial for GEN-003 HSV-2 Immunotherapy 7:02 a.m. July 21, 2014 - BusinessWire - BZX
Genocea Biosciences, Inc. Elects Not to Pursue Public Offering 10:30 a.m. July 16, 2014 - BusinessWire - BZX
Genocea Biosciences, Inc. Commences Public Offering of Common Stock 6:30 a.m. July 14, 2014 - BusinessWire - BZX
Genocea Announces Positive Top-Line 12-Month Follow-up Data from Phase 1/2a Clinical Trial for HSV-2 Immunotherapy GEN-003 7:02 a.m. July 1, 2014 - BusinessWire - BZX
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer 6:30 a.m. June 24, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼